Bhashaja Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.80 M
- Revenue Growth 0.90%
- Profit Growth 15.69%
- Ebitda -7.52%
- Net Worth 0.48%
- Total Assets 0.37%
About Bhashaja Pharmaceuticals
Bhashaja Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 August 2010 and has a history of 14 years and five months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹2.80 M.
Sonali Mukherjee and Tapas Jana serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110WB2010PTC152614
-
Company No.
152614
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Aug 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Bhashaja Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonali Mukherjee
|
Additional Director | 27-Dec-2010 | Current |
|
Tapas Jana
|
Director | 28-Aug-2010 | Current |
Financial Performance of Bhashaja Pharmaceuticals.
Bhashaja Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.9% increase. The company also saw a substantial improvement in profitability, with a 15.69% increase in profit. The company's net worth moved up by a moderate rise of 0.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhashaja Pharmaceuticals?
In 2018, Bhashaja Pharmaceuticals had a promoter holding of 30.53% and a public holding of 69.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sera Health Care Centre Private LimitedTapas Jana is a mutual person
Charges (Loans)
₹2.80 M
₹0
Charges Breakdown by Lending Institutions
- Corporation Bank : 0.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2015 | Corporation Bank | ₹1.30 M | Open |
| 23 Jun 2012 | Corporation Bank | ₹1.50 M | Open |
How Many Employees Work at Bhashaja Pharmaceuticals?
Unlock and access historical data on people associated with Bhashaja Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhashaja Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhashaja Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
